A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

NCT01804140 · clinicaltrials.gov ↗
COMPLETED
Status
662
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Genentech, Inc.